NCT02190058

Multiple Dose Study of DS-1971a

A PHASE I, DOUBLE-BLIND, RANDOMISED, PLACEBO-CONTROLLED, MULTIPLE-DOSE STUDY TO ASSESS SAFETY, TOLERABILITY AND PHARMACOKINETICS OF DS-1971A IN HEALTHY MALE SUBJECTS

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 32 (actual)
• Sponsor: Daiichi Sankyo · Industry
• Sex: Male
• Age: 18 Years – 55 Years
• Healthy volunteers: Accepted

Summary

This is a randomised, double-blind, placebo-controlled multiple dose study designed to explore the safety, tolerability and PK of DS-1971a following oral administration over 14 days to healthy male subjects.

Conditions

• Healthy

Interventions

Type	Name	Description
DRUG	DS-1971a	suspension
DRUG	placebo	placebo matching DS-1971a

Timeline

• Start date: 2014-07-01
• Primary completion: 2014-11-01
• Completion: 2014-11-01
• First posted: 2014-07-15
• Last updated: 2018-12-24

Locations

1 site across 1 country: United Kingdom